MedPath

The Prevalence of Erectile Dysfunction (ED) and Premature Ejaculation (PE) in Poland

Completed
Conditions
Erectile Dysfunction
Premature Ejaculation
Registration Number
NCT05462171
Lead Sponsor
Jagiellonian University
Brief Summary

The first large population-based study to evaluate erectile dysfunction (ED) and premature ejaculation (PE) in Poland. The study objective is to assess the prevalence and bother of ED and PE in the representative group of male population of Poland.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
3000
Inclusion Criteria
  • Age ≥18
  • A sufficient level of education to understand study procedures and be able to communicate with site personnel
Exclusion Criteria

• Age <18

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of PE in PolandThrough study completion, an average of 3 months

The prevalence of PE will be assessed using the Premature Ejaculation Diagnostic Tool (PEDT; the lowest score 0; the highest score 20; the lower the score, the lower the severity of the symptoms)

Prevalence of ED in PolandThrough study completion, an average of 3 months

The prevalence of ED will be assessed using the five-item International Index of Erectile Function (IIEF-5; the lowest score 5; the highest score 25; the lower the score, the greater the severity of the symptoms)

Secondary Outcome Measures
NameTimeMethod
Bother of ED and PE in PolandThrough study completion, an average of 3 months

The degree of associated bother will be assessed using Likert scale (Likert scale: delighted \[score 0\], pleased \[score 1\], mostly satisfied \[score 2\], mixed \[score 3\], mostly dissatisfied \[score 4\], unhappy \[score 5\], or terrible \[score 6\]).

Prevalence of lower urinary tract symptoms in patients with PE and ED in PolandThrough study completion, an average of 3 months

The prevalence of lower urinary tract symptoms will be assessed with the International Prostate Symptom Score (IPSS; the lowest score 0, the highest score 35, the lower the score, the lower the severity of the symptoms)

Prevalence of insomnia in patients with PE and ED in PolandThrough study completion, an average of 3 months

The prevalence of insomnia will be assessed with the Athens Insomnia Scale (AIS; the lowest score 0; the highest score 24; the lower the score, the lower the severity of the symptoms)

Prevalence of depressive symptoms in patients with PE and ED in PolandThrough study completion, an average of 3 months

The prevalence of depressive symptoms will be assessed with the Hospital Anxiety and Depression Scale (HADS; the lowest score 0; the highest score 48; the lower the score, the lower the severity of the symptoms)

Prevalence of overactive bladder in patients with PE and ED in PolandThrough study completion, an average of 3 months

The prevalence of overactive bladder will be assessed with the Overactive Bladder - Validated 8-question Screener (OAB-V8; the lowest score 0; the highest score 40; the lower the score, the lower the severity of the symptoms)

Trial Locations

Locations (1)

Department of Urology, Jagiellonian University

🇵🇱

Krakow, Malopolskie, Poland

© Copyright 2025. All Rights Reserved by MedPath